$RYAN

Kuczinski Anthony J purchased $105K of RYAN

Kuczinski Anthony J purchased 3,000 shares of RYAN SPECIALTY HOLDINGS, INC. (RYAN) at an average of $34.99 ($34.83–$35.77, $0.10M total) across 2 trades over 2026-06-11 to 2026-06-12.

Original reporting
SEC EDGAR · Kuczinski Anthony J
Published Jun 15, 2026, 8:32 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 15, 2026, 8:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RYAN
Bullish
medium confidence
Mentioned
$RYAN
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RYANBullishLow
01

Why it matters

The newest concrete fact is the director’s open-market purchase details (shares, price range, total value) disclosed on 2026-06-15.

02

Market read

Traders may treat the filing as a small sentiment input, but it does not introduce earnings, guidance, or regulatory/contract catalysts.

03

What to watch

No 10b5-1 plan is cited, but the trades were spread across two days and the article provides no context on prior holdings, options, or compensation-driven activity.

Relevance 5/10Novelty 6/10Timing: Filed 2026-06-15; trades occurred 2026-06-11 to 2026-06-12.

Background

The article is an SEC Form 4 insider transaction disclosure for RYAN Specialty Holdings, Inc.

Company-level read

Ticker impact

$RYANBullishMedium confidence
Context

SEC Form 4 shows director Anthony J. Kuczinski bought 3,000 shares of RYAN Specialty Holdings at $34.83–$35.77 (avg $34.99).

Expected impact

Likely limited near-term impact; any effect is more sentiment/positioning than earnings or guidance-driven.

Evidence & confidence

The filing is a routine Form 4 insider buy with modest size relative to company fundamentals and no accompanying operational or financial disclosure.

Market effects

Minimal; insider buying in a single issuer typically does not reset sector expectations.

None indicated.

None indicated.

Counterpoint

A director buy can be driven by diversification, liquidity planning, or non-informational motives; it may not reflect near-term performance.

Key entities

  • RYAN Specialty Holdings, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Anthony J. Kuczinski

    Director who purchased 3,000 shares in open-market trades.

Related articles

$RYANMedAI 8/10

Ryan Specialty posts Q2 revenue gain as E&S market slows

Ryan Specialty Holdings, Inc. reported second-quarter 2026 net commissions and fees of $902.7 million, up 7.4% year-over-year. Total revenue for the quarter reached $916.6 million, a 7.2% increase from $855.2 million a year earlier. Organic revenue growth came in at 6.7%, down from 7.1% in the prior-year period. The deceleration continues a trend across multiple quarters as the broader E&S market moderates.

$RYANMed

RYAN SPECIALTY HOLDINGS, INC. (RYAN): Results of Operations and Financial Condition

RYAN SPECIALTY HOLDINGS, INC. (RYAN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ryan-20260630xex991.htm EX-99.1 RYAN-2026.06.30-EX 99.1 1 RYAN SPECIALTY REPORTS SECOND QUARTER 2026 RESULTS - Total Revenue grew 7.2% year-over-year to $916.6 million - - Organic Revenue Growth Rate* of 6.7% year-over-year - - Net Income of $108.4 million , or $0.33 pe